Hypoxia induces apoptosis in primary and transformed cells and in various tumor cell lines in vitro. In contrast, there is little apoptosis and predominant necrosis despite extensive hypoxia in human glioblastomas in vivo. We here characterize ultrastructural and biochemical features of cell death in LN-229, LN-18 and U87MG malignant glioma cells in a paradigm of hypoxia with partial glucose deprivation in vitro. Electron microscopic analysis of hypoxia-challenged glioma cells demonstrated early stages of apoptosis but predominant necrosis. ATP levels declined during hypoxia, but recovered with re-exposure to normoxic conditions unless hypoxia exceeded 8 h. Longer hypoxic exposure resulted in irreversible ATP depletion and delayed cell death. Hypoxia induced mitochondrial release of cytochrome c, but there was no cleavage of caspases 3, 7, 8 or 9, and no DNA fragmentation. Ectopic expression of BCL-X L conferred protection from hypoxia-induced cell death, whereas the overexpression of the antiapoptotic proteins X-linked-inhibitor-of-apoptosisprotein and cytokine response modifier-A had no effect. These findings suggest that glioma cells resist adverse effects of hypoxia until energy stores are depleted and then undergo necrosis rather than apoptosis because of energy deprivation.
Introduction
Extensive hypoxia is a hallmark of glioblastoma and other solid tumors. [1] [2] [3] Already at early stages of tumorigenesis, tumor hypoxia may be precipitated by regression of co-opted host vasculature, resulting in hypoxic tumor cell death and thus selective pressure for hypoxia-resistant clones. 4, 5 Ultimately, however, the remaining tumor is rescued by robust angiogenesis at the tumor margin. In established tumors, chronic hypoxia is caused by increased metabolic activity and rapid tumor cell growth outscaling tumor neoangiogenesis and compromising the vascular supply of oxygen and nutrients. In addition, acute tumor hypoxia can be brought about by tumor vessel occlusion via thrombosis 6, 7 or by fluctuations in the oxygenation of disordered tumor vasculature. 8, 9 Further, antiangiogenic therapeutic strategies can result in hypoxia and tumor cell death. 10, 11 Tumor hypoxia is relevant for (i) the selection of clones resistant to hypoxia-induced cell death and (ii) the biological behavior and response to therapy of the hypoxic tumor cell fraction. Hypoxia-induced cell death in E1A and Ha-rastransformed cell lines, 12 several nonglioma tumor cell lines 13, 14 and nontransformed cells 15 may take place predominantly by apoptosis in vitro. In contrast, glioblastoma cell death in vivo is predominantly necrotic, 7, 16 while the amount of apoptosis is generally low. 17 Apoptotic changes defined by DNA strand breaks detected by terminal dUTP in situ nick end-labeling (TUNEL) are predominantly located among pseudopalisading perinecrotic cells 18, 19 which express vascular endothelial growth factor (VEGF), 20 suggesting focal areas of hypoxia and a graded response of glioma cells to hypoxia. The small amount of apoptosis despite extensive tumor hypoxia suggests the development of resistance to hypoxia-induced apoptosis in glioblastomas by alterations in the cell death pathway including both short-term effects such as upregulation of antiapoptotic proteins 21 and genetic selection for cells with defects in the apoptotic pathway. 12, 22, 23 The apparent resistance to hypoxia-induced cell death translates also into clinical relevant adverse outcomes, since there is a worse prognosis for patients with extensively hypoxic solid tumors, 6, 24 while both a higher amount of apoptosis and a low ratio of proliferation to apoptosis in glioblastomas may indicate a better prognosis.
We here characterized the mode and biochemical features of hypoxia-induced cell death in malignant glioma cell lines in vitro. To model realistic conditions of the tumor microenvironment, we restricted glucose concentration in the medium to 2 mM for the hypoxic incubations, since many experimental studies have shown similar decreases in glucose concentration in the center of solid tumors in parallel to increasing hypoxia. [27] [28] [29] In particular, we studied ATP levels during hypoxia, since the mode of cell death can be ATP-dependent, with ATP acting as a molecular switch between apoptosis and necrosis in some paradigms.
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Results
Predominant necrosis and abortive apoptotic changes in hypoxia-induced cell death
The morphological features of hypoxia-induced glioma cell death were characterized by electron microscopy (EM). Primarily, cell death after hypoxia followed by normoxic recovery for 24 h with replenishment of glucose was studied. In the LN-229 cell line, there were only few cells which displayed apoptotic features at early time points, including cytoplasmic blebbing, nuclear chromatin condensation and margination with rare formation of apoptotic bodies. Necrotic changes, including mitochondrial swelling and organelle disruption, cytoplasmic vesiculation, vacuolization and rupture of the cell membrane at later time points were predominant (Figure 1a-d) . In U87MG cells, early apoptotic changes were more pronounced, and cytoplasmic integrity was better preserved in the initial stages. However, at later time points, there was necrosis similar to LN-229 cells ( Figure  1e-h ). LN-229 cells were prepared for EM also directly following hypoxia of 8, 12 and 16 h to analyze early morphological changes. There were necrotic changes similar to those described above, but nuclear chromatin condensation and margination were less pronounced (cells exposed to hypoxia for 16 h are shown in Figure 1i ). For comparison of typical apoptotic changes, LN-229 cells were exposed to (CD95 ligand) CD95L in a parallel experiment (Figure 1j) .
In LN-18 cells, the morphological consequences of hypoxia occurred earlier than in LN-229 and U87MG cells. To investigate the time course of cell death induction, LN-18 cells were fixed for electron microscopy directly after hypoxia (Figure 2a-d) or after a 24 h period of normoxic recovery (Figure 2e-h) . Compared with the morphology seen immediately after hypoxia, more prominent early apoptotic features developed in a delayed fashion after 8 and 12 h of hypoxia and subsequent further culturing at normoxia, with nuclear chromatin condensation and formation of apoptotic bodies in some cells. As in the LN-229 and U87MG cell lines, necrotic changes prevailed at later time points, ultimately leading to cell membrane disruption. The classical ultrastructural end stages of apoptosis (pyknotic cells with fragmented nuclei and apoptotic bodies, preserved cell membrane) which occur in these cells after treatment with death ligands, Teniposide (VM26), or other stimuli as described in previous studies [32] [33] [34] did not develop in either cell line during hypoxia-induced cell death.
No specific Annexin V binding occurs during hypoxic cell death
To further characterize the mode of hypoxic cell death in this paradigm, Annexin V binding assays were performed in LN-18 and LN-229 cells. No specific apoptotic changes (i.e. Annexin V binding in cells not taking up propidium iodide, lower right quadrant) were detected. Some propidium iodide positive cells also stained positive for Annexin V, a finding consistent 
Progressive ATP depletion during hypoxia determines hypoxic cell death
To analyze cellular energy homeostasis during hypoxia and subsequent normoxic recovery of glioma cells, ATP levels were monitored in LN-229 cells and correlated with cell death as assessed by LDH release. At 4 and 8 h of hypoxia, cellular ATP levels were reduced, but recovered during additional normoxic incubation with glucose supplementation ( Figure  4a ). While cell death took place during hypoxia (white bars in Figure 4b ), there was no further delayed cell death during the recovery period following 4 and 8 h of hypoxia (black bars in Figure 4b ). In contrast, ATP stores were irreversibly depleted at 12 h of hypoxia and at later time points, and delayed cell death occurred.
Hypoxic cell death is dependent on glucose concentration
To define the threshold for glucose concentrations in the medium necessary for survival under hypoxic conditions, LN-229 cells were incubated under hypoxia with glucose concentrations of 2 mM, 5 mM and full serum-free medium (25 mM glucose). At a starting concentration of 2 mM, glucose was less than 1 mM at H8, where significant cell death emerged (Figure 5a ). 25 mM and 5 mM glucose in the media protected the cells from hypoxia-induced cell death ( Figure  5b ,c). In addition, glucose concentrations above 2 mM protected against hypoxia-induced ATP depletion as described previously 35 and cytochrome c release (data not shown).
Mitochondrial cytochrome c release fails to promote caspase processing during hypoxia-induced cell death
To characterize the hypoxia-induced cell death pathway at a biochemical level, mitochondrial cytochrome c release, caspase processing and DNA fragmentation were examined as three salient features typically accompanying apoptosis. There was pronounced cytochrome c release from mitochondria into the cytosol from H8 on in LN-229 cells (Figure 6a ). Similar results were obtained in LN-18 and U87MG cells (not shown). Swelling of mitochondria with distortion of the cristae was observed in LN-229 cells exposed to hypoxia for 8 h and immediately thereafter prepared for electron microscopy as a possible morphological correlate of mitochondrial injury ( Figure 6b ). In contrast to other models of cell death, the observed release of cytochrome c failed to promote the processing of caspases 3, 7, 8 and 9 during hypoxia-induced cell death in LN-18 cells. In contrast, caspase cleavage was 
Ectopic expression of BCL-X L protects glioma cells from hypoxia-induced cell death
Although mitochondrial damage and the release of cytochrome c are commonly modulated by BCL-2 family proteins, the protein levels of BCL-2, BCL-X L and BAX remained unchanged during hypoxia (data not shown). BCL-X L has been shown to protect from hypoxic cell death, and previous work from our laboratory has shown that ectopic expression of BCL-X L in LN-18 and LN-229 cells also inhibits death receptor-mediated apoptosis presumably by preventing mitochondrial cytochrome c release. 36 We therefore investigated hypoxia-induced cell death in LN-18 and LN-229 cells transfected with BCL-X L : enhanced expression of BCL-X L conferred significant protection from hypoxia-induced cell death in both cell lines. Results for LN-18 cells are shown in Figure 7a (note that the difference between LN-18 neo and LN-18 BCL-X L was not statistically significant at H20). However, BCL-X L did not prevent hypoxia-induced ATP depletion (results for LN-18 cells are shown in Figure 7a ). This is compatible with anaerobic extramitochondrial ATP generation under hypoxia and a model where mitochondrial injury might be a consequence of energy depletion rather than its cause.
To further characterize the role of inhibitors of apoptosis, LN-229 cells were transduced with a vector encoding the Xlinked-inhibitor-of-apoptosis-protein (XIAP) or a green fluorescent protein (GFP) control vector by adenoviral gene transfer. While XIAP protected cells from CD95L-induced apoptosis under normoxia (Figure 7b , left), it did not protect against hypoxic cell death. To ascertain proper function of the adenovirally transferred XIAP also under hypoxic conditions, we exposed the cells to hypoxia in the presence of CD95L: XIAP was protective solely against the additional cell death caused by CD95L (Figure 7b, right) .
Similar, ectopic expression of the viral caspase 8 inhibitor cytokine response modifier-A (crm-A) in LN-229 cells did not confer protection from hypoxic cell death, while efficiently inhibiting CD95 ligand-induced apoptosis (Figure 7c ). Despite the lack of detectable caspase cleavage, incubation of LN-18 cells with the broad spectrum protease inhibitor zVAD-fmk conferred protection against hypoxic cell death (Figure 7d ). In contrast, the more specific inhibitors of caspases 3 and 9, zDEVD-fmk and zLEHD-fmk, respectively, did not protect against hypoxia-induced cell death (Figure 7d ). The effect of zVAD-fmk was already detectable immediately following hypoxia, with no additional protection generated during normoxic recovery, and similar data were obtained in LN-229 cells (not shown).
Discussion
Here we have characterized the features of hypoxic cell death of malignant glioma cell lines in vitro in a paradigm of profound hypoxia and partial glucose deprivation. In contrast to classical apoptotic cell death induced by hypoxia in E1A and Ha-ras-transformed cell lines, 12 several nonglioma tumor cell lines 13, 14 and nontransformed cells, 15 only early morphological features of apoptosis, but predominant necrosis, became evident by ultrastructural and biochemical analysis in the glioma cell lines. Since the glioma cells investigated in this study are proficient to undergo caspase activation and apoptosis in response to death ligands or cytotoxic drugs, 33 specific mechanisms must account for the absence of hypoxia-induced apoptosis. Antiapoptotic molecules expressed by glioma cells may prevent hypoxic stimuli from activating the cell death program as long as energy resources and organelle integrity are preserved. Ultimately, cell death ensues when the available nutrients, for example, glucose, are consumed, and cellular ATP is progressively depleted. 30 This notion is supported by the protection of the glioma cell lines from hypoxia-induced cell death by higher concentrations of glucose, as described earlier for kidney cells 37 and astrocytes.
38 Consistent with this model, cells surviving shorter periods of hypoxia were able to recover and reconstitute normal ATP levels, without the occurrence of delayed cell death. However, once ATP levels were profoundly depleted, progressive cell death ensued even during normoxic incubation with glucose replenishment (Figure 4) . Disruption of mitochondria is likely to account for the inability of cells to recover from these conditions. 37 However, it is notable that delayed cell death following reconstitution of ATP levels after mitochondrial injury in other models is apoptotic. 30, 37 In most paradigms of apoptosis, cytochrome c release results in the formation of a complex, the apoptosome, involving caspase 9 and apoptotic protease activating factor 1 (APAF 1), leading to the cleavage of caspase 9 and subsequently apoptotic cell death. However, ATP is required for the cleavage of caspase 9 by the apoptosome. 39, 40 Under conditions of energy failure, caspase 9 activation and subsequent effector caspase activation may be incomplete. 41 This mechanism in conjunction with the expression of apoptosis-inhibitory proteins of the inhibitor-of-apoptosisprotein (IAP) and BCL-2 family 42, 43 may explain the absence of caspase cleavage and end stages of apoptosis in our paradigm. However, if there is no caspase cleavage, why does zVAD-fmk protect against hypoxia-induced cell death? Since neither XIAP, which acts on both caspases 3 and 8, nor crm-A, which acts predominantly on caspase 8, or the more specific caspase inhibitors zDEVD-fmk and zLEHD-fmk alter hypoxia-induced cell death, the protection provided by zVADfmk may be related to the inhibition of caspases other than 3, 7 ,8 or 9, or to effects of zVAD-fmk on noncaspase proteases. With regard to this possibility, it is well recognized that zVAD does not exclusively inhibit caspases (for review of other proteases and references for noncaspase-specific actions of zVAD.fmk see Leist and Jaattela 44 ). Indeed, inhibition of calpain, the activation of which contributes to necrosis during hypoxic-hypoglycemic-injury (reviewed in Wang 45 ) by zVADfmk, has been observed. 46 We have also considered the possibility of secondary necrosis in our system, which can especially occur following failed apoptosis, for the changes observed following hypoxia and additional normoxic recovery. However, since there was no detectable apoptosis by morphological and biochemical criteria also immediately following hypoxia even at the shortest incubation times resulting in detectable cell death, we dismissed this notion.
Hypoxic cell death in glioma cells resembles death induced by cytotoxic drugs, staurosporine or UV light in APAF 1 knockout embryonic stem cells which undergo nonapoptotic caspase-independent cell death. BCL-2 protects APAF 1 knockout cells by preserving mitochondrial membrane potential independent from caspase activation. 47 The protection afforded by ectopic BCL-X L expression in our experiments is therefore probably caused by stabilization of mitochondria against hypoxia-induced damage. 37 ,47,48 APAF 1-and caspase 3-independent cell death may comprise peripheral chromatin condensation (stage I) similar to our results, in the absence of oligonucleosomal DNA fragmentation. Release of apoptosis inducing factor (AIF) from mitochondria 
-test). (c) Phase contrast images of LN-229 cells exposed to hypoxia (H20) or normoxia (N) for 20 h in the presence of 2 and 5 mM glucose or serum-free medium (25 mM glucose) followed by 24 h of normoxic recovery
may act as the critical effector for this phenomenon. 49 The primary cause of hypoxia-induced mitochondrial injury is unclear. Possibly, ATP depletion itself leads to loss of mitochondrial membrane potential and the observed morphological alterations. Cytochrome c released from mitochondria may then cause an arrest of electron transport within the respiratory chain, resulting in the production of membranedamaging free radicals and cessation of mitochondrial ATP production, further paving the way towards cell death. 50 In contrast to paradigms where a death stimulus is applied and only the mode of cell death is ATP-dependent, hypoxia per se might not be a sufficient death stimulus in this system. Therefore, we consider energy deprivation as the possible primary cause of cell death in contrast to the models studied by Leist et al. 30 and others, on which the concept of ATP as a molecular switch between apoptosis and necrosis is based.
Caspase-independent death of cancer cells is increasingly recognized as an important mechanism with implications for the development of novel cancer therapies. Our findings correspond to the predominance of necrosis over apoptosis in human glioblastoma in vivo despite extensive hypoxia, 7, 16 , and it appears likely that our model mimics the conditions faced by many tumor cells in the microenvironment of human glioblastoma. Further, the sensitivity of glioma cells to the induction of apoptosis by hypoxia may be important for antiangiogenic therapies, which in other solid tumors so far have had disappointing results in clinical trials. Insight into the mechanisms opposing hypoxia-induced apoptosis may result in strategies to sensitize tumor cells to hypoxia and enhance the impact of antiangiogenic therapy. Finally, this model will be valuable for the study of the effects of other therapies aiming to induce cell death in the hypoxic tumor cell fraction.
Materials and Methods
Reagents and cell lines
N-acetyl-Asp-Glu-Val-Asp-7-methyl-4-aminocoumarin (DEVD-amc), Z-Val-AlaAsp-fluoromethylketone (zVAD-fmk) and Z-Leu-Glu-His-Asp-7-methyl- 4-fluoromethylketone (zLEHD-fmk) were obtained from Bachem (Heidelberg, Germany). Z-Asp-Glu-Val-Asp-7-methyl-4-fluoromethylketone (zDEVD-fmk) was obtained from Calbiochem (Schwalbach, Germany). Teniposide (VM26) was obtained from Bristol (Munich, Germany). All other chemicals not specified below were purchased from Sigma (Deisenhofen, Germany). CD95 ligand (CD95L) was obtained from the supernatant of CD95L-transfected N2A murine neuroblastoma cells. 51 LN-18 (p53 mutant), LN-229 and U87MG (both p53 wildtype) human malignant glioma cell lines have been characterized previously. 43 LN-18 and LN-229 cells transfected with the pSFFV-BCL-X L construct or an empty neo control vector have been described. 36 LN-229 crm-A cells were obtained using the Flag-crm-A-puro construct and were compared with puromycin-resistant control cells transfected with the empty vector.
Adenoviral gene transfer of XIAP was performed as described. 42 Briefly, cells were infected with XIAP-adenovirus or GFP control adenovirus at a multiplicity of infection (MOI) of 300. At 24 h after infection, the virus-containing supernatant was removed and cells were incubated under hypoxic or normoxic conditions for the times indicated. Cell death was assessed immediately following hypoxia by LDH-assay. The glioma cells were maintained in DMEM containing 10% fetal calf serum, 2 mM glutamine, 100 IU/ml penicillin and 100 mg/ml streptomycin.
Induction of hypoxia
Cells were plated on glass petri dishes of various sizes with cell density adjusted to 5 Â 10 5 cells/cm 2 or on glass 96-well plates (Hellma, Mühlheim, Germany) at a density of 2.5 Â 10 4 /well and allowed to attach in medium containing 10% fetal calf serum for 24 h. Then the medium was removed and the cells were incubated in serum-free DMEM without glucose (Gibco BRL, Basel, Switzerland) adjusted to 2 mM glucose under normoxia or hypoxia. The experimental conditions have been described previously. 52, 53 Briefly, the cells were incubated in sealed chambers exposed to a mixture of 200 ppm O 2 , 5% CO 2 and 95% argon or normoxic control conditions in a humified atmosphere. After hypoxia for the times indicated, the cells were allowed to recover for 24 h with replenishment of glucose to 12.5 mM and addition of 1% fetal calf serum. For some experiments, the cells were prepared for analysis either immediately after hypoxia or after the 24 h recovery period. No decrease in pH o7.2 occurred under these conditions. Alternatively, hypoxia was induced chemically by incubating the plates in Gas Pak pouches for anaerobic culture (Becton Dickinson, Heidelberg, Germany). 54 This procedure results in hypoxia of less than 0.4% O 2 with 4-10% of CO 2 after 100 min. The Gas Pak technique was extensively characterized and yielded identical results compared to gassing with 0.02% O 2 with 5% CO 2 as judged by LDH release assay, caspase cleavage, glucose and ATP depletion and ultrastructural features of cell death.
Electron microscopy
Glioma cells grown in 60 mm plates and treated as indicated were fixed in 2.5% glutaraldehyde (Paesel-Lorei, Frankfurt, Germany) in Hank's modified salt solution (HMSS), postfixed in 1% OsO 4 in 0.1 M cacodylate buffer, scraped off the plastic and dehydrated in ethanol. The 70% ethanol step was saturated with uranyl acetate for contrast enhancement. Dehydration was completed in propylene oxide. The specimens were embedded in Araldite (Serva, Heidelberg, Germany). Ultrathin sections were produced on an FCR Reichert Ultracut ultramicrotome (Leica, Bensheim, Germany), mounted on pioloform-coated copper grids and contrasted with lead citrate. Specimens were analyzed and documented with an EM 10A electron microscope (Zeiss, Oberkochen, Germany). Immediately following hypoxia, cell death was assessed by LDH release assay (*Po0.05 for the comparison of vehicle versus zVAD-fmk, student's t-test). In a parallel experiment, LN-18 cells were exposed to CD95L in the presence of 50 mM zVADfmk, zDEVD-fmk, zLEHD-fmk or vehicle for 24 h. Survival was assessed by crystal violet staining
Viability assays
The cells were seeded in 96-well plates and allowed to attach for 24 h. The cells were exposed to hypoxia or normoxia and treated as indicated. Immediately following hypoxia or after recovery under normoxia, the plates were centrifuged, and the LDH concentration in the supernatant was assessed employing the cell death detection kit II (Boehringer Mannheim, Mannheim, Germany). Crystal violet staining was performed as described. 51 
DEVD-amc-cleaving caspase activity
The cells were seeded in 96-well plates and allowed to attach for 24 h. The cells were exposed to hypoxia or normoxia and lysed immediately after hypoxia in buffer containing 25 mM Tris-HCl (pH 8.0), 60 mM NaCl, 2.5 mM EDTA and 0.25% NP40 for 10 min. DEVD-amc (12.5 mM) diluted in PBS was added and incubated at 371C for 10 min. Caspase activity was measured for 1 h using a CytoFluor 2350 Millipore fluorimeter at 360 nm excitation and 480 nm emission wavelengths.
DNA fragmentation assay
The cells were grown in 60 mm plates, allowed to attach for 24 h and exposed to hypoxia or normoxia. After normoxic recovery, the cells were pelleted by centrifugation (7 min, 1200 rpm, 41C). The pellet was dissolved in lysis buffer (10 mM Tris-HCl, pH 7.5, 10 mM EDTA, 0.2% Triton X-100) and lysed for 10 min at 41C. The lysates were centrifuged at 13 000 rpm and 41C. Supernatant was taken for the measurement of fragmented DNA. The pellet with the intact DNA was again dissolved in lysis buffer and sonified for 20 s. RNase (100 mg/ml) was added to all samples. RNA was digested for 2 h at 371C. All samples were diluted in buffer containing 5 mM TRIS-HCl, pH 7.5, 0.5 mM EDTA and 0.5 mg/ml ethidium bromide and measured for the content of DNA using a CytoFluor 2350 Millipore fluorimeter at 530 nm excitation and 620 nm emission wavelengths.
Immunoblot analysis
The cells were grown on 60 mm plates. Immediately after hypoxia or normoxia, the cells were washed with cold PBS, harvested into ice-cold PBS containing phenylmethyl-sulfonylfluoride (PMSF) (10 mg/ml) with a cell scraper, lysed in lysis buffer containing 50 mM Tris-HCl, pH 8, 120 mM NaCl, 0.5% NP-40, 100 mg/ml PMSF, 10 mg/ml leupeptin and 2 mg/ml aprotinin, for 15 min on ice and centrifuged at 13 000 rpm for 10 min at 41C. The protein concentration was determined by the Bio-Rad Protein Assay (Bio-Rad, Munich, Germany). Soluble proteins (20 mg/lane) were separated by SDS-PAGE and blotted to nitrocellulose by standard procedures. Equal loading was ascertained by Ponceau S staining. The membranes were pretreated for 2 h with PBS containing 5% skim milk, 0.05% Tween 20 and then incubated for 16 h at 41C with antibodies to caspase 3, BCL-X L (Transduction Laboratories, Lexington, KY, USA), caspases 7, 9 (kindly supplied by Dr. Y Lazebnik, Cold Spring Harbor, NY, USA), caspase 8 (kindly supplied by Dr. PH Krammer, Heidelberg, Germany), BCL-2 (PharMingen, San Diego, CA, USA), BAX and actin (Santa Cruz, San Diego, CA, USA). The secondary antibodies, protein A and anti-mouse IgG, were purchased from Amersham (Braunschweig, Germany), anti-goat antibody was from Santa Cruz. Enhanced chemiluminescence (ECL+, Amersham) was used for detection.
Cytochrome c release assay
The cells were grown in 100 mm plates. After hypoxia and immediately following recovery under normoxia, the cells were washed with PBS and cytoplasmatic cytochrome c was extracted by permeabilization with mannitol, sucrose, HEPES (MSH) buffer plus digitonin (210 mM Dmannitol, 70 mM sucrose, 10 mM HEPES, 200 mM EGTA, 5 mM succinate, 0.15% BSA, 40 mg/ml digitonin) at 41C. After lysis, the supernatant was removed and centrifuged immediately for 10 min at 13 000 Â g. An equal volume of 10% trichloroacetic acid was added to the supernatant. Samples were kept at -201C for at least 30 min. After another centrifugation (15 min at 13000 x g), the pellets were dissolved in sample buffer (50 mM TRIS-HCl, pH 6.8, 2% SDS, 0.1% bromophenolblue, 10% glycerol) and analyzed for cytochrome c content by SDS-PAGE and immunoblot, employing mouse monoclonal cytochrome c antibody from PharMingen (San Diego, CA, USA). The mitochondrial cytochrome c content was analyzed by SDS-PAGE from the pellet fraction.
Annexin V binding assay
The cells were exposed to hypoxia or normoxia as described above. Immediately after hypoxia, or after 24 h recovery as specified, the cells were washed and stained with propidium iodide and Annexin V (Becton Dickinson PharMingen, Heidelberg, Germany) according to the instructions of the manufacturer. Specific binding was analyzed by FACS utilizing a Becton Dickinson FACSCalibur and the Cell Quest software.
ATP assay
The cells were exposed to hypoxia or normoxia as described above. Immediately after hypoxia, or after 24 h recovery as specified, the plates were placed on ice, and the cells were pelleted by centrifugation and lysed in ATP releasing agent (Sigma). ATP was determined by luciferase assay with the CLS II kit (Boehringer Mannheim, Mannheim, Germany). 30 Typical absolute values for normoxic control cells grown in serum-free medium containing 2 mM glucose were in the region of 2.8 nM ATP/mg protein. Values were normalized for LDH release to detect the ATP levels in surviving cells and are given in percentage of values in normoxic control cells. There was no decline in ATP levels >15% for up to 20 h of normoxia with serum-free medium and 2 mM glucose (not shown).
Glucose assay
The cells were exposed to hypoxia or normoxia as described above. Immediately after hypoxia, the cells were pelleted by centrifugation and the glucose concentration in the supernatant was determined employing the Gluco-quant Glucos/HK Kit (Roche, Basel, Switzerland).
Statistical analysis
Data are commonly representative of three independent experiments with similar results. Quantitative data are expressed as means and S.D. of triplicate experiments and were assessed for significance by Student's ttest.
